Abingworth is a leading transatlantic life sciences investment firm. Abingworth helps transform cutting-edge science into novel medicines by providing capital and expertise to top caliber management teams building world-class companies. Since 1973, Abingworth has invested in over 180 life science companies, leading to 46 M&As and 70+ IPOs. Our therapeutic focused investments fall into three categories: seed and early-stage, development stage, and clinical co-development. Abingworth supports its portfolio companies with a team of experienced professionals at offices in London, Menlo Park (California), and Boston. Abingworth became part of Carlyle (NASDAQ: CG) on 1 August 2022.
Looking for a particular Abingworth employee's phone or email?
Abingworth Questions
The Abingworth annual revenue was $17.4 million in 2026.
Tim Haines is the Managing Director and Executive Partner of Abingworth.
22 people are employed at Abingworth.
The NAICS codes for Abingworth are [52, 5239, 54, 541, 523].
The SIC codes for Abingworth are [67, 62, 679, 628].
Top Abingworth Employees
-
Tim Haines
Managing Director and Executive Partner at Abingworth
London, England, GB25+ -
Kurt von Emster
Managing Partner, Head of Life Sciences at Abingworth
Menlo Park, CA, US25+ -
Jayson Punwani
Managing Director at Abingworth
Menlo Park, CA, US25 -
Ankur Shah
Vice President at Abingworth
New York, NY, US25+ -
David Mayer
Partner at Abingworth
Boston, MA, US35+ -
David Leathers
Director at Abingworth
London, GB13 -
Diya Malhotra
Principal at Abingworth
London, GB23 -
Graham Mills
Principal at Abingworth
London, GB25
Related Companies
